BACE1 relative levels were nearly six times higher in the DS-AD group compared to the HC group, while the BACE1 levels in the EOAD group exhibited were nearly twice as high as in the HC group (Figure 8F). The gene discussed is BACE1; the disease is Alzheimer disease.